Abstract
Whilst the scientific community was celebrating the truly momentous discovery of a ‘mixed function oxidase’ another oxidase was quietly working behind the scenes, mopping up soft nucleophiles and, as it had undoubtedly being doing for aeons, aiding then unknown in the metabolism of xenobiotics and the protection of life forms. This enzyme, flavin mono-oxygenase, has subsequently been shown to be a major player, if not yet an equal partner with cytochrome(s) P450, in the metabolism of both endogenous biochemicals and foreign compounds that enter the human organism. This article outlines the importance of the flavin mono-oxygenases and examines their susceptibility to activity modulation by exogenous factors.
Keywords: Flavin mono-oxygenase, Zeigler's enzyme, trimethylamine, fish-odour syndrome, hormones, cruciferous vegetables
Current Drug Metabolism
Title: Flavin Mono-Oxygenase (FMO) - The ‘Other’ Oxidase
Volume: 9 Issue: 4
Author(s): S. C. Mitchell
Affiliation:
Keywords: Flavin mono-oxygenase, Zeigler's enzyme, trimethylamine, fish-odour syndrome, hormones, cruciferous vegetables
Abstract: Whilst the scientific community was celebrating the truly momentous discovery of a ‘mixed function oxidase’ another oxidase was quietly working behind the scenes, mopping up soft nucleophiles and, as it had undoubtedly being doing for aeons, aiding then unknown in the metabolism of xenobiotics and the protection of life forms. This enzyme, flavin mono-oxygenase, has subsequently been shown to be a major player, if not yet an equal partner with cytochrome(s) P450, in the metabolism of both endogenous biochemicals and foreign compounds that enter the human organism. This article outlines the importance of the flavin mono-oxygenases and examines their susceptibility to activity modulation by exogenous factors.
Export Options
About this article
Cite this article as:
Mitchell C. S., Flavin Mono-Oxygenase (FMO) - The ‘Other’ Oxidase, Current Drug Metabolism 2008; 9 (4) . https://dx.doi.org/10.2174/138920008784220682
DOI https://dx.doi.org/10.2174/138920008784220682 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon
Current Drug Targets Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity
Letters in Drug Design & Discovery Intermittent Transient Motor Aphasia Associated with Acute Lithium Toxicity: A Case Report and Brief Review
Current Drug Safety The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Extracellular Vesicles and Insulin Resistance: A Potential Interaction in Vascular Dysfunction
Current Vascular Pharmacology Analysis of Process and Formulation Variables on Chitosan based Losartan Potassium Nanoparticles: Preparation, Validation and in vitro Release Kinetics
Recent Innovations in Chemical Engineering Effects of an Antihypertensive Combination in Japanese Hypertensive Outpatients Based on the Long-acting Calcium Channel Blocker Benidipine on Vascular and Renal Events: A Sub-analysis of the COPE Trial
Current Hypertension Reviews Targeting Angiogenesis in Rheumatoid Arthritis
Current Rheumatology Reviews An update on the Management and Treatment of Deep Vein Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors
Current Pharmaceutical Design Nanoceuticals as an Emerging Field: Current Status and Future Prospective
Current Nutrition & Food Science Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo
Current Alzheimer Research The Different Ways through Which Specificity Works in Orthosteric and Allosteric Drugs
Current Pharmaceutical Design Author Index To Volume 2
Current Hypertension Reviews Glycoprotein Targeting and Other Applications of Lectins in Biotechnology
Current Protein & Peptide Science ENaC and Its Regulatory Proteins as Drug Targets for Blood Pressure Control
Current Drug Targets Pharmacogenomics of Cardiovascular Complications in Diabetes and Obesity
Recent Patents on Biotechnology Meet Our Associate Editor:
Cardiovascular & Hematological Disorders-Drug Targets